HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MLN8054

antineoplastic; an orally active small-molecule inhibitor of Aurora A kinase; structure in first source
Also Known As:
4-((9-chloro-7-(2,6-difluorophenyl)-5H-pyrimidol(5,4-d)(2)benzazepin-2-yl)amino)benzoic acid
Networked: 18 relevant articles (0 outcomes, 6 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Stringer, Bradley: 4 articles (04/2011 - 03/2007)
2. Bowman, Douglas: 4 articles (02/2011 - 06/2007)
3. Ecsedy, Jeffrey A: 4 articles (02/2011 - 03/2007)
4. Danaee, Hadi: 3 articles (04/2011 - 10/2010)
5. Ecsedy, Jeffrey: 3 articles (04/2011 - 11/2008)
6. Galvin, Katherine: 3 articles (04/2011 - 06/2007)
7. Liu, Hua: 3 articles (04/2011 - 10/2010)
8. Chakravarty, Arijit: 3 articles (02/2011 - 06/2007)
9. Shinde, Vaishali: 3 articles (02/2011 - 06/2007)
10. Zhang, Mengkun: 3 articles (02/2011 - 03/2007)

Related Diseases

1. Neoplasms (Cancer)
2. Prostatic Neoplasms (Prostate Cancer)
3. Aneuploidy (Aneuploid)
4. Melanoma (Melanoma, Malignant)
5. Thyroid Neoplasms (Thyroid Cancer)

Related Drugs and Biologics

1. Aurora Kinase A
2. Nocodazole
3. Biomarkers (Surrogate Marker)
4. Aurora Kinases
5. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
6. Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
7. Mitogen-Activated Protein Kinase Kinases (MEKs)
8. Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
9. von Willebrand Factor
10. Epidermal Growth Factor (EGF)

Related Therapies and Procedures

1. Oral Administration